Brief: Cardiol Therapeutics Announces $15 Mln Bought Deal Public Offering
05/05/2021 22:03
May 5 (Reuters) - Cardiol Therapeutics Inc CRDL.TO :
* CARDIOL THERAPEUTICS ANNOUNCES $15 MILLION BOUGHT DEAL
PUBLIC
OFFERING
* CARDIOL THERAPEUTICS INC - UNDERWRITERS HAVE AGREED TO
PURCHASE,
ON A BOUGHT DEAL BASIS, 4.2 MILLION UNITS AT PRICE OF $3.60 PER
UNIT
Source text for Eikon: ID:nGNXb6TKVN
Further company coverage: CRDL.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cardiol Therapeutics
See all newsBrief: Cardiol Therapeutics Achieves Phase III Maveric Enrollment Target Ahead Of Schedule And Expands Pivotal Trial To Strengthen Assessment Of Cardiolrx's Efficacy
Brief: Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus
Brief: Cardiol Therapeutics Files For Mixed Shelf Offering Of Up To $150 Mln
Brief: Cardiol Therapeutics Initiated Pivotal Phase Iii Maveric Trial Of Cardiolrx In Recurrent Pericarditis
NASDAQ RESUMED AT 09:00 AM